<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04066426</url>
  </required_header>
  <id_info>
    <org_study_id>16.02.2018/12</org_study_id>
    <nct_id>NCT04066426</nct_id>
  </id_info>
  <brief_title>Comparison of Different Drugs on Pain and Trismus in Patients With Temporomandibular Disorder</brief_title>
  <official_title>Comparison of Effects of Naproxen Sodium-codeine Phosphate in Combination, Naproxen Sodium + Single Dose Dexamethasone and Naproxen Sodium Alone on Pain and Trismus in Patients With Temporomandibular Disorder</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Yuzuncu Yıl University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Yuzuncu Yıl University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Temporomandibular disorders (TMDs) are one of the most common muco-skeletal disorders, seen
      in the dental clinics.1 Many factors work together to initiate or aggravate the condition, so
      it is a multifactorial disorder. The etiology of TMDs maybe a result of parafunctional habits
      such as clenching and bruxism, acute trauma to the jaw, trauma from hyperextension e.g. after
      a long dental treatment, joint laxity, psychological distress, occlusal disharmony like
      presence of high crown or free-end saddle leading to joint instability or systemic diseases
      such as Rheumatoid arthritis or Osteoarthritis. The aim of this study was to evaluate the
      effects of naproxen sodium+codeine phosphate, naproxen sodium+dexamethasone, and naproxen
      sodium on pain and trismus in patients complaining from temporomandibular pain.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">March 1, 2018</start_date>
  <completion_date type="Actual">July 15, 2019</completion_date>
  <primary_completion_date type="Actual">April 1, 2019</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Factorial Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Pain evaluation</measure>
    <time_frame>Evaluations were carried out pre-treatment (baseline) and at the first week, second week and first month during treatment.</time_frame>
    <description>Evaluation of changes in Visual Analog Scale (VAS) measurements by groups</description>
  </primary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">169</enrollment>
  <condition>Temporomandibular Disorder</condition>
  <arm_group>
    <arm_group_label>naproxen sodium+codeine phosphate</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Naproxen sodium is a propionic acid derivative with analgesic, antipyretic, and antiinflammatory properties. Its mechanism of action relies on the inhibition of prostaglandin synthesis, and significant pain relief and plasma levels can be obtained within 20 minutes following intake. The elimination half-life of naproxen sodium is reportedly around 14 hours, and naproxen sodium is used in doses ranging from 275 to 550 mg in surgical procedures. Codeine phosphate is an opioid analgesic which has similar applications to those of morphine. However, it is significantly less potent as an analgesic and has only mild sedative effects. The drug's principal site of action is at the µ-opioid receptors (MOR) which are distributed in the central nervous system. Peak effect is reached within 2 hours and analgesic action continues for approximately 4 hours. Naproxen sodium (550 mg)+codeine phosphate (30 mg) was used twice daily in this study.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>naproxen sodium+dexamethasone</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Naproxen sodium is a propionic acid derivative with analgesic, antipyretic, and antiinflammatory properties. Its mechanism of action relies on the inhibition of prostaglandin synthesis, and significant pain relief and plasma levels can be obtained within 20 minutes following intake. The elimination half-life of naproxen sodium is reportedly around 14 hours, and naproxen sodium is used in doses ranging from 275 to 550 mg in surgical procedures. Naproxen sodium (550 mg) was used twice daily + dexamethasone (8 mg) was used once daily in this study.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>naproxen sodium</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Naproxen sodium is a propionic acid derivative with analgesic, antipyretic, and antiinflammatory properties. Its mechanism of action relies on the inhibition of prostaglandin synthesis, and significant pain relief and plasma levels can be obtained within 20 minutes following intake. The elimination half-life of naproxen sodium is reportedly around 14 hours, and naproxen sodium is used in doses ranging from 275 to 550 mg in surgical procedures. Naproxen sodium (550 mg) was used twice daily in this study.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>paracetamol</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Paracetamol is a mild analgesic and antipyretic, and is recommended for the treatment of most painful and febrile conditions, for example, headache including migraine, toothache, neuralgia, colds and influenza, sore throat, backache, rheumatic pain and dysmenorrhoea.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>naproxen sodium+codeine phosphate, naproxen sodium+dexamethasone, naproxen sodium, paracetamol</intervention_name>
    <description>NSAID, steroid, opioid, paracetamol and combinations of this drugs can be used in temporomandibular disorders.</description>
    <arm_group_label>naproxen sodium</arm_group_label>
    <arm_group_label>naproxen sodium+codeine phosphate</arm_group_label>
    <arm_group_label>naproxen sodium+dexamethasone</arm_group_label>
    <arm_group_label>paracetamol</arm_group_label>
    <other_name>Anaprox Double Strength (DS) + Codeine, Anaprox DS + Decadron, Anaprox DS, Parmol</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Without a systemic disease,

          -  Not used any medication in the last week

          -  Have a habit of clenching and / or grinding teeth, individuals with normal
             preoperative results, suffering with pain and / or limitation of the mouth opening in
             the temporomandibular region

        Exclusion Criteria:

        Individuals who smoke

          -  Have a parafunctional habits (except for squeezing and grinding teeth)

          -  Pregnant and breastfeeding individuals

          -  Allergies to study medicines

          -  Do not use their medications / use different drugs and non-follow-up
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Volkan KAPLAN, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Faculty of dentistry</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Van Yuzuncu Yil University, Faculty of Dentistry</name>
      <address>
        <city>Van</city>
        <state>Tuşba</state>
        <zip>65080</zip>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <verification_date>August 2019</verification_date>
  <study_first_submitted>August 17, 2019</study_first_submitted>
  <study_first_submitted_qc>August 22, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">August 26, 2019</study_first_posted>
  <last_update_submitted>August 22, 2019</last_update_submitted>
  <last_update_submitted_qc>August 22, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">August 26, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Yuzuncu Yıl University</investigator_affiliation>
    <investigator_full_name>levent Cigerim</investigator_full_name>
    <investigator_title>Head of Oral and Maxillofacial Surgery Department</investigator_title>
  </responsible_party>
  <keyword>naproxen sodium</keyword>
  <keyword>codeine phosphate</keyword>
  <keyword>dexamethasone</keyword>
  <keyword>pain</keyword>
  <keyword>trismus</keyword>
  <keyword>temporomandibular joint</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Temporomandibular Joint Disorders</mesh_term>
    <mesh_term>Temporomandibular Joint Dysfunction Syndrome</mesh_term>
    <mesh_term>Trismus</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Acetaminophen</mesh_term>
    <mesh_term>Dexamethasone</mesh_term>
    <mesh_term>Naproxen</mesh_term>
    <mesh_term>Codeine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

